Report: Diabetes Dx market to hit $32B by 2017

It may be obvious to point out that the worldwide explosion of diabetes is expanding the market for diagnostics to assess the disease. But Global Industry Analysts is offering something new by quantifying how much that expansion will be. The firm predicts in a new report that the global diabetes diagnostics market will reach $32 billion by 2017. That increase will be driven by rising disease incidence, heightened awareness, and a two-year recovery in the sector after a recession-driven slowdown in 2008 and 2009. Improved diagnostic technology also has helped, according to the report. Companies that make blood glucose meters and monitors, blood glucose test strips, lancets and related equipment all stand to gain in the coming years, GIA notes. Release

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.